China Digest: Arctic Vision raises $32m; Topgen snags $17m

Chinese biotech firm Arctic Vision has raised $32 million in a Series A round of financing led by Morningside Ventures, while Shanghai Topgen Pharmaceuticals has closed 120 million yuan ($17 million) in a Series C funding round.